Please try another search
Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products, as well as intermediates of antiviral drugs. It also provides contract research, development, and manufacturing services, as well as engages in lithium battery electrolyte additives. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.
Name | Age | Since | Title |
---|---|---|---|
Hong Liu | 63 | 2014 | Independent Director |
Rong Wu Cheng | 54 | 2012 | Director |
Huiyue Li | 59 | - | Vice Chairman of the Board |
Jian Hua Bao | 46 | 2012 | GM & Chairman |
Hai Bin Yang | 51 | 2012 | Chairman of Supervisory Board |
Wen Jun Yu | 62 | 2012 | Director |
Dan Ke | 47 | 2020 | Director |
Ting Ye | 38 | 2019 | Member of Supervisory Board |
Wei Dong | 45 | 2012 | Manager of the Sales Department & Member of Supervisory Board |
Yan Li | 66 | 2012 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review